Alternatively spliced MDM2 transcripts in human breast cancer in relation to tumor necrosis and lymph node involvement

被引:23
作者
Hori, M
Shimazaki, J
Inagawa, S
Itabashi, M
Hori, M
机构
[1] Ibaraki Prefectural Cent Hosp & Canc Ctr, Dept Pathol, Tomobe, Ibaraki 3091703, Japan
[2] NIAID, Immunopathol Lab, NIH, Bethesda, MD 20892 USA
关键词
human breast cancer; MDM2; oncogene; splice variant mRNA; tumor necrosis;
D O I
10.1046/j.1440-1827.2000.01119.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Several short forms of alternatively spliced Murine double minute 2 (MDM2) transcripts have recently been shown to correlate with high-grade malignancy in a number of human tumors. We examined the frequency of splice variants and their correlation with clinicopathological features in 60 cases of human breast cancer. Seven short forms coexpressed with wild-type mRNA were detected by nested RT-PCR. Sequencing of all the MDM2 variants demonstrated mRNA splicing which disrupted not only the conserved p53-binding domain but also, further towards the carboxy-terminus, the conserved nuclear localization sequence and/or the acidic and zinc finger domains. There was no significant correlation between the coexpression of splice variants and tumor size, histologic type or hormone (estrogen and progesterone) receptor status. However, cases with spliced MDM2 transcripts tended to be of a more aggressive type with axillary lymph node involvement and extensive necrosis in the tumors. Although the functional significance of MDM2 variants remains obscure, we anticipate that these variants will be confirmed as a novel prognostic marker in human breast cancer.
引用
收藏
页码:786 / 792
页数:7
相关论文
共 25 条
[1]   ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER [J].
ALLRED, DC ;
CLARK, GM ;
ELLEDGE, R ;
FUQUA, SAW ;
BROWN, RW ;
CHAMNESS, GC ;
OSBORNE, CK ;
MCGUIRE, WL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) :200-206
[2]  
Baunoch DA, 1996, INT J ONCOL, V8, P895
[3]   RELATIONSHIP OF NECROSIS AND TUMOR BORDER TO LYMPH-NODE METASTASES AND 10-YEAR SURVIVAL IN CARCINOMA OF BREAST [J].
CARTER, D ;
PIPKIN, RD ;
SHEPARD, RH ;
ELKINS, RC ;
ABBEY, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1978, 2 (01) :39-46
[4]   TUMORIGENIC POTENTIAL ASSOCIATED WITH ENHANCED EXPRESSION OF A GENE THAT IS AMPLIFIED IN A MOUSE-TUMOR CELL-LINE [J].
FAKHARZADEH, SS ;
TRUSKO, SP ;
GEORGE, DL .
EMBO JOURNAL, 1991, 10 (06) :1565-1569
[5]   Functions of the MDM2 oncoprotein [J].
Freedman, DA ;
Wu, L ;
Levine, AJ .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) :96-107
[6]  
GUDAS JM, 1995, CLIN CANCER RES, V1, P71
[7]   AN IMMUNOHISTOCHEMICAL STUDY OF P53 WITH CORRELATIONS TO HISTOPATHOLOGICAL PARAMETERS, C-ERBB-2, PROLIFERATING CELL NUCLEAR ANTIGEN, AND PROGNOSIS [J].
HAERSLEV, T ;
JACOBSEN, GK .
HUMAN PATHOLOGY, 1995, 26 (03) :295-301
[8]   COMPARISON OF THE PROGNOSTIC VALUE OF 4 METHODS TO ASSESS MITOTIC-ACTIVITY IN 186 INVASIVE BREAST-CANCER PATIENTS - CLASSICAL AND RANDOM MITOTIC-ACTIVITY ASSESSMENTS WITH CORRECTION FOR VOLUME PERCENTAGE OF EPITHELIUM [J].
JANNINK, I ;
VANDIEST, PJ ;
BAAK, JPA .
HUMAN PATHOLOGY, 1995, 26 (10) :1086-1092
[9]  
*JAP BREAST CANC S, 1998, GEN RUL CLIN PATH RE
[10]  
JOHNSTON SRD, 1995, CANCER RES, V55, P3331